Verona Pharma Plc Company Profile (LON:VRP)

About Verona Pharma Plc

Verona Pharma Plc logoVerona Pharma plc is a United Kingdom-based bio-pharmaceutical company. The Company is engaged in developing drugs for the treatment of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis. Its program is RPL554, an inhaled, dual phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4) inhibitors, as a nebulized treatment for patients in hospital with acute exacerbation of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. RPL554 has completed two double-blind placebo controlled randomized Phase II b studies of RPL554: one in mild to moderate asthma and another in mild to moderate COPD. Its other products include VRP700 and NAIPs. VRP700 is an anti-tussive (cough) drug and has completed a Phase II trial. The Company's subsidiaries include Rhinopharma Limited and Verona Pharma Inc.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: VRP
  • CUSIP:
Key Metrics:
  • Previous Close: $0.04
  • 50 Day Moving Average: $3.10
  • 200 Day Moving Average: $3.30
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $78.25B
  • Outstanding Shares: 1,009,923,000
Additional Links:

Analyst Ratings

Consensus Ratings for Verona Pharma Plc (LON:VRP) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Verona Pharma Plc (LON:VRP)
DateFirmActionRatingPrice TargetDetails
1/28/2016N+1 SingerReiterated RatingCorporateView Rating Details
(Data available from 8/26/2014 forward)


Earnings History for Verona Pharma Plc (LON:VRP)
No earnings announcements for this company have been tracked by


Earnings Estimates for Verona Pharma Plc (LON:VRP)
Current Year EPS Consensus Estimate: $-0.51 EPS


Dividend History for Verona Pharma Plc (LON:VRP)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Verona Pharma Plc (LON:VRP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2016Jan-Anders Karlsson,SvenInsiderBuy600,000GBX 3£18,000
1/20/2016Ebsworth,DavidInsiderBuy400,000GBX 3£12,000
12/3/2015Ebsworth,DavidInsiderBuy370,000GBX 3£11,100
6/17/2015David EbsworthInsiderBuy250,000GBX 4.70£11,750
5/18/2015David EbsworthInsiderBuy300,000GBX 3.50£10,500
3/3/2015David EbsworthInsiderBuy450,000GBX 2.43£10,935
2/16/2015Biresh RoyInsiderBuy500,000GBX 2.30£11,500
2/13/2015Sven Jan-Anders KarlssonInsiderBuy1,025,909GBX 2£20,518.18
2/4/2015David EbsworthInsiderBuy700,000GBX 1.54£10,780
1/19/2015Stuart BottomlyInsiderBuy1,000,000GBX 1.50£15,000
1/13/2015David EbsworthInsiderBuy803,107GBX 1.35£10,841.94
(Data available from 1/1/2013 forward)


Latest Headlines for Verona Pharma Plc (LON:VRP)
DateHeadline logoVERONA PHARMA : Notice of Results (LON:VRP) - August 10 at 11:25 AM
News IconVERONA PHARMA PLC - Notice of Results (LON:VRP) - August 10 at 11:25 AM logoDirector's Dealing (LON:VRP) - August 10 at 11:25 AM logoHalf Year 2016 Verona Pharma PLC Earnings Release - Before Market Open (LON:VRP) - August 10 at 11:25 AM logoVERONA PHARMA PLC - Grant of Share Options (LON:VRP) - August 4 at 11:27 AM logoVerona Pharma : Admission of Placing Shares (LON:VRP) - July 30 at 10:51 AM
News IconVERONA PHARMA PLC - Admission of Placing Shares (LON:VRP) - July 30 at 10:51 AM logoAdmission of Placing Shares (LON:VRP) - July 29 at 3:38 AM logoVerona Pharma : Result of General Meeting (LON:VRP) - July 23 at 7:26 PM
News IconVERONA PHARMA PLC - Result of GM (LON:VRP) - July 23 at 7:26 PM logoConfirmation of General Meeting Date (LON:VRP) - July 3 at 2:31 AM logoVERONA PHARMA PLC - Notice of GM (LON:VRP) - July 2 at 10:43 AM logoInvestor News from Veritas Pharma (LON:VRP) - June 28 at 7:19 AM logoLondon stocks hold onto gains as Brexit fears fade (LON:VRP) - June 21 at 7:37 PM logoNASDAQ listing for Verona Pharma? (LON:VRP) - June 21 at 7:37 PM logoProposed Placing to raise c. £44.7 million and Notice of General Meeting (LON:VRP) - June 17 at 3:19 PM logoAGM Notice & Annual Report (2) (LON:VRP) - June 17 at 3:19 PM logoVerona Pharma reports progress but losses rise (LON:VRP) - June 4 at 11:23 AM logoAGM Notice & Annual Report (LON:VRP) - June 3 at 12:45 PM logoQ4 2015 Verona Pharma PLC Earnings Release - Time Not Supplied (LON:VRP) - June 3 at 7:07 AM logoFinancial Results for year ended 31 December 2015 (LON:VRP) - June 3 at 2:45 AM logoPREVIEW - All eyes on US jobs number Friday (LON:VRP) - June 2 at 8:44 PM
News IconAnalyst Coverage Updates - Verona Pharma (LON:VRP) - Risers & Fallers (LON:VRP) - February 26 at 11:53 AM logoVERONA PHARMA : Grant of Share Options (LON:VRP) - February 11 at 2:57 PM logoVerona Pharma Plc Just Recorded A Sigfniciant Decline - (LON:VRP) - February 4 at 1:52 PM logoVerona Pharma PLC (VRP) (LON:VRP) - January 21 at 12:33 PM logoStart of RPL554 Phase IIa combination study (LON:VRP) - October 14 at 8:31 AM logoPositive headline data from RPL554 clinical study in COPD patients (LON:VRP) - September 29 at 6:57 AM logoFurther RPL544 Phase 2a trial commences (LON:VRP) - June 11 at 4:06 AM logoRPL554 MAD study in COPD patients commences (LON:VRP) - June 8 at 3:37 AM logoNotice of posting 2014 Annual Report (LON:VRP) - May 13 at 12:07 PM logoAudited Results for the 12 months ended 31 December 2014 (LON:VRP) - May 12 at 3:38 AM


Last Updated on 8/26/2016 by Staff